New Wave of Biosimilar Drugs May Boost Generics ETF
April 15, 2016 at 14:37 PM EDT
Expensive biologics have weighed on health care consumers. However, as the government tries to contain the soaring costs, a generic drugs-related exchange traded fund could capitalize on the growth of cheaper biosimilars. The Market Vectors Generic Drugs ETF (NasdaqGM: GNRX) tries to reflect the...